RADIANT-T cells therapy (Baylor College of Medicine)

N/A

Report date: 2026/05/22 20:01:29

Base Information

Drug NameRADIANT-T cells therapy (Baylor College of Medicine)
Drug Alias Name21.15.GPC3-CAR T Cells therapy (Baylor College of Medicine)GPC-3 CAR T CELLSGO-CART T cellsGPC-3 Chimeric Antigen Receptor T Cells
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector +[4] 
Mechanisms of ActionGlypican-3 modulatorsInterleukin-15 receptors agonistsInterleukin 21 Receptor agonists
TargetsGlypican-3Interleukin-15 receptorsInterleukin 21 Receptor
Therapy Area/IndicationsTeratomaGlioblastomaRhabdoid Tumor
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBaylor College Of Medicine
Inactive CompaniesN/A
Active IndicationsTeratomaGlioblastomaRhabdoid Tumor
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A